top of page

Dave Flory, MBA

Chief Development Officer

Mr. Flory is a biotech executive with a passion for developing novel therapeutics and optimizing product development timelines. Prior to Kuria, Mr. Flory was Senior Director of Drug Development at Unicycive, where he helped lead the development of a portfolio of compounds, including those targeting mitochondrial function. Prior to Unicycive, Mr. Flory spent over 10 years at Reata Pharmaceuticals developing novel Nrf2 activators. Mr. Flory was Director of Project Management & Integration, responsible for oversight of the entire Nrf2 clinical development portfolio. Mr. Flory also earned significant experience in Alliance Management while at Reata, overseeing a complex collaboration with a major pharma partner. Mr. Flory holds a BS in Biology from UCLA, and an MBA from UC Davis.

bottom of page